Prothena Corporation plc [PRTA] to Ring the NASDAQ Stock Market Opening Bell

Published: Feb 12, 2013

ADVISORY, Feb. 12, 2013 (GLOBE NEWSWIRE) --

What:

Prothena [PRTA], a biotechnology company focused on the discovery and development of novel antibodies for the potential treatment of a broad range of diseases, will visit the NASDAQ MarketSite in Times Square.

Back to news